|
Guest
|
Most recent articles on breast cancer:
Leptin enhances growth inhibition by cAMP elevating agents through
apoptosis of MDA-MB-231 breast cancer cells.
Naviglio S, Di Gesto D, Sorrentino A, Illiano F, Sorvillo L,
Abbruzzese A, Monica M, Michele C, Chiosi E, Spina A, Illiano G.
Cancer Biol Ther. 2009 Jun;8(12):1183-90.
silvio.naviglio at (no spam) unina2.it
Effects of 5-Aza-CdR on the proliferation of human breast cancer cell
line MCF-7 and on the expression of Apaf-1 gene.
Xiong H, Qiu H, Zhuang L, Xiong H, Jiang R, Chen Y.
J Huazhong Univ Sci Technolog Med Sci. 2009 Aug;29(4):498-502.
xionghuihua at (no spam) medmail.com.cn
Clinicopathological characteristics of recurrence more than 10 years
after surgery in patients with breast carcinoma.
Takeuchi H, Muto Y, Tashiro H.
Anticancer Res. 2009 Aug;29( :3445-8.
t3996 at (no spam) beppu.hosp.go.jp
Methylation mediated silencing of TMS1 in breast cancer and its
potential contribution to docetaxel cytotoxicity.
Gordian E, Ramachandran K, Singal R.
Anticancer Res. 2009 Aug;29(:3207-10.
Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-
alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase
(PI3K)/Akt pathway in human breast cancer cells.
Chang HL, Sugimoto Y, Liu S, Wang LS, Huang YW, Ye W, Lin YC.
Anticancer Res. 2009 Aug;29(:3195-205.
Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and
ovarian cancer.
Dombernowsky SL, Weischer M, Freiberg JJ, Bojesen SE, Tybjaerg-Hansen
A, Nordestgaard BG.
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(:2339-42.
Circulating estrogen metabolites and risk for breast cancer in
premenopausal women.
Arslan AA, Shore RE, Afanasyeva Y, Koenig KL, Toniolo P, Zeleniuch-
Jacquotte A.
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(:2273-9.
Breast cancer receptor status: do results from a centralized pathology
laboratory agree with SEER registry reports?
Ma H, Wang Y, Sullivan-Halley J, Weiss L, Burkman RT, Simon MS, Malone
KE, Strom BL, Ursin G, Marchbanks PA, McDonald JA, Spirtas R, Press
MF, Bernstein L.
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(:2214-20.
Visual impairment in myopic patients with breast cancer receiving
adjuvant therapy with aromatase inhibitors.
Epstein RJ.
Clin Breast Cancer. 2009 Aug;9(3):184-6.
Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With
HER2-Overexpressing Metastatic Breast Cancer.
Yardley DA, Burris Iii HA, Hanson S, Greco FA, Spigel DR, Barton J,
Hainsworth JD.
Clin Breast Cancer. 2009 Aug;9(3):178-83.
Pilot study of targeted skeletal radiation therapy for bone-only
metastatic breast cancer.
Ueno NT, de Souza JA, Booser D, Nakayama K, Madewell J, Wendt Iii RE,
Hortobagyi GN, Podoloff D, Champlin RE.
Clin Breast Cancer. 2009 Aug;9(3):173-7.
A Phase II Trial of a Neoadjuvant Platinum Regimen for Locally
Advanced Breast Cancer: Pathologic Response, Long-Term Follow-up, and
Correlation With Biomarkers.
Yerushalmi R, Hayes MM, Gelmon KA, Chia S, Bajdik C, Norris B, Speers
C, Hassell P, O'Reilly SE, Allan S, Shenkier TN.
Clin Breast Cancer. 2009 Aug;9(3):166-72.
InTextoResearch, Baelen, Liège, Wallonie (Wallonia), Belgique
(Belgium) & Agence Wallonne d’Information Scientifique (AWIS) (Marc
Lacroix, scimedweb at (no spam) mail.com) |
|
|
